Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Palbociclib|DRUG: Goserelin|DIAGNOSTIC_TEST: Oncotype DX Breast Recurrence Score
Sponsor: NSABP Foundation Inc
Collaborators: Genomic Health®, Inc.|Pfizer